Global BCG Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-GuŠ¹rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
According to APO Research, The global BCG Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of BCG Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for BCG Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of BCG Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for BCG Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the BCG Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global BCG Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for BCG Vaccine sales, projected growth trends, production technology, application and end-user industry.
BCG Vaccine segment by Company
1. To analyze and research the global BCG Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions BCG Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify BCG Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze BCG Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of BCG Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the BCG Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global BCG Vaccine industry.
Chapter 3: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of BCG Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of BCG Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-GuŠ¹rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
According to APO Research, The global BCG Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for BCG Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of BCG Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for BCG Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of BCG Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for BCG Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the BCG Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global BCG Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for BCG Vaccine sales, projected growth trends, production technology, application and end-user industry.
BCG Vaccine segment by Company
- Merck
- Sanofi Pasteur
- Japan BCG Lab
- China National Biotec
- Serum Institute of India
- Intervax
- GSBPL
- Immune BCG
- Therapy BCG
- Hospitals
- Clinics
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global BCG Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions BCG Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify BCG Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze BCG Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of BCG Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the BCG Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global BCG Vaccine industry.
Chapter 3: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of BCG Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of BCG Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global BCG Vaccine Sales Value (2019-2030)
1.2.2 Global BCG Vaccine Sales Volume (2019-2030)
1.2.3 Global BCG Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 BCG VACCINE MARKET DYNAMICS
2.1 BCG Vaccine Industry Trends
2.2 BCG Vaccine Industry Drivers
2.3 BCG Vaccine Industry Opportunities and Challenges
2.4 BCG Vaccine Industry Restraints
3 BCG VACCINE MARKET BY COMPANY
3.1 Global BCG Vaccine Company Revenue Ranking in 2023
3.2 Global BCG Vaccine Revenue by Company (2019-2024)
3.3 Global BCG Vaccine Sales Volume by Company (2019-2024)
3.4 Global BCG Vaccine Average Price by Company (2019-2024)
3.5 Global BCG Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global BCG Vaccine Company Manufacturing Base & Headquarters
3.7 Global BCG Vaccine Company, Product Type & Application
3.8 Global BCG Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global BCG Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 BCG Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 BCG VACCINE MARKET BY TYPE
4.1 BCG Vaccine Type Introduction
4.1.1 Immune BCG
4.1.2 Therapy BCG
4.2 Global BCG Vaccine Sales Volume by Type
4.2.1 Global BCG Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global BCG Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global BCG Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global BCG Vaccine Sales Value by Type
4.3.1 Global BCG Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global BCG Vaccine Sales Value by Type (2019-2030)
4.3.3 Global BCG Vaccine Sales Value Share by Type (2019-2030)
5 BCG VACCINE MARKET BY APPLICATION
5.1 BCG Vaccine Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Others
5.2 Global BCG Vaccine Sales Volume by Application
5.2.1 Global BCG Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global BCG Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global BCG Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global BCG Vaccine Sales Value by Application
5.3.1 Global BCG Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global BCG Vaccine Sales Value by Application (2019-2030)
5.3.3 Global BCG Vaccine Sales Value Share by Application (2019-2030)
6 BCG VACCINE MARKET BY REGION
6.1 Global BCG Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global BCG Vaccine Sales by Region (2019-2030)
6.2.1 Global BCG Vaccine Sales by Region: 2019-2024
6.2.2 Global BCG Vaccine Sales by Region (2025-2030)
6.3 Global BCG Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global BCG Vaccine Sales Value by Region (2019-2030)
6.4.1 Global BCG Vaccine Sales Value by Region: 2019-2024
6.4.2 Global BCG Vaccine Sales Value by Region (2025-2030)
6.5 Global BCG Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America BCG Vaccine Sales Value (2019-2030)
6.6.2 North America BCG Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe BCG Vaccine Sales Value (2019-2030)
6.7.2 Europe BCG Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific BCG Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific BCG Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America BCG Vaccine Sales Value (2019-2030)
6.9.2 Latin America BCG Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa BCG Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa BCG Vaccine Sales Value Share by Country, 2023 VS 2030
7 BCG VACCINE MARKET BY COUNTRY
7.1 Global BCG Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global BCG Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global BCG Vaccine Sales by Country (2019-2030)
7.3.1 Global BCG Vaccine Sales by Country (2019-2024)
7.3.2 Global BCG Vaccine Sales by Country (2025-2030)
7.4 Global BCG Vaccine Sales Value by Country (2019-2030)
7.4.1 Global BCG Vaccine Sales Value by Country (2019-2024)
7.4.2 Global BCG Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Merck BCG Vaccine Product Portfolio
8.1.5 Merck Recent Developments
8.2 Sanofi Pasteur
8.2.1 Sanofi Pasteur Comapny Information
8.2.2 Sanofi Pasteur Business Overview
8.2.3 Sanofi Pasteur BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 Sanofi Pasteur BCG Vaccine Product Portfolio
8.2.5 Sanofi Pasteur Recent Developments
8.3 Japan BCG Lab
8.3.1 Japan BCG Lab Comapny Information
8.3.2 Japan BCG Lab Business Overview
8.3.3 Japan BCG Lab BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Japan BCG Lab BCG Vaccine Product Portfolio
8.3.5 Japan BCG Lab Recent Developments
8.4 China National Biotec
8.4.1 China National Biotec Comapny Information
8.4.2 China National Biotec Business Overview
8.4.3 China National Biotec BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 China National Biotec BCG Vaccine Product Portfolio
8.4.5 China National Biotec Recent Developments
8.5 Serum Institute of India
8.5.1 Serum Institute of India Comapny Information
8.5.2 Serum Institute of India Business Overview
8.5.3 Serum Institute of India BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Serum Institute of India BCG Vaccine Product Portfolio
8.5.5 Serum Institute of India Recent Developments
8.6 Intervax
8.6.1 Intervax Comapny Information
8.6.2 Intervax Business Overview
8.6.3 Intervax BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 Intervax BCG Vaccine Product Portfolio
8.6.5 Intervax Recent Developments
8.7 GSBPL
8.7.1 GSBPL Comapny Information
8.7.2 GSBPL Business Overview
8.7.3 GSBPL BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 GSBPL BCG Vaccine Product Portfolio
8.7.5 GSBPL Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 BCG Vaccine Value Chain Analysis
9.1.1 BCG Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 BCG Vaccine Sales Mode & Process
9.2 BCG Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 BCG Vaccine Distributors
9.2.3 BCG Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global BCG Vaccine Sales Value (2019-2030)
1.2.2 Global BCG Vaccine Sales Volume (2019-2030)
1.2.3 Global BCG Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 BCG VACCINE MARKET DYNAMICS
2.1 BCG Vaccine Industry Trends
2.2 BCG Vaccine Industry Drivers
2.3 BCG Vaccine Industry Opportunities and Challenges
2.4 BCG Vaccine Industry Restraints
3 BCG VACCINE MARKET BY COMPANY
3.1 Global BCG Vaccine Company Revenue Ranking in 2023
3.2 Global BCG Vaccine Revenue by Company (2019-2024)
3.3 Global BCG Vaccine Sales Volume by Company (2019-2024)
3.4 Global BCG Vaccine Average Price by Company (2019-2024)
3.5 Global BCG Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global BCG Vaccine Company Manufacturing Base & Headquarters
3.7 Global BCG Vaccine Company, Product Type & Application
3.8 Global BCG Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global BCG Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 BCG Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 BCG VACCINE MARKET BY TYPE
4.1 BCG Vaccine Type Introduction
4.1.1 Immune BCG
4.1.2 Therapy BCG
4.2 Global BCG Vaccine Sales Volume by Type
4.2.1 Global BCG Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global BCG Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global BCG Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global BCG Vaccine Sales Value by Type
4.3.1 Global BCG Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global BCG Vaccine Sales Value by Type (2019-2030)
4.3.3 Global BCG Vaccine Sales Value Share by Type (2019-2030)
5 BCG VACCINE MARKET BY APPLICATION
5.1 BCG Vaccine Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Others
5.2 Global BCG Vaccine Sales Volume by Application
5.2.1 Global BCG Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global BCG Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global BCG Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global BCG Vaccine Sales Value by Application
5.3.1 Global BCG Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global BCG Vaccine Sales Value by Application (2019-2030)
5.3.3 Global BCG Vaccine Sales Value Share by Application (2019-2030)
6 BCG VACCINE MARKET BY REGION
6.1 Global BCG Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global BCG Vaccine Sales by Region (2019-2030)
6.2.1 Global BCG Vaccine Sales by Region: 2019-2024
6.2.2 Global BCG Vaccine Sales by Region (2025-2030)
6.3 Global BCG Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global BCG Vaccine Sales Value by Region (2019-2030)
6.4.1 Global BCG Vaccine Sales Value by Region: 2019-2024
6.4.2 Global BCG Vaccine Sales Value by Region (2025-2030)
6.5 Global BCG Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America BCG Vaccine Sales Value (2019-2030)
6.6.2 North America BCG Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe BCG Vaccine Sales Value (2019-2030)
6.7.2 Europe BCG Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific BCG Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific BCG Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America BCG Vaccine Sales Value (2019-2030)
6.9.2 Latin America BCG Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa BCG Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa BCG Vaccine Sales Value Share by Country, 2023 VS 2030
7 BCG VACCINE MARKET BY COUNTRY
7.1 Global BCG Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global BCG Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global BCG Vaccine Sales by Country (2019-2030)
7.3.1 Global BCG Vaccine Sales by Country (2019-2024)
7.3.2 Global BCG Vaccine Sales by Country (2025-2030)
7.4 Global BCG Vaccine Sales Value by Country (2019-2030)
7.4.1 Global BCG Vaccine Sales Value by Country (2019-2024)
7.4.2 Global BCG Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global BCG Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global BCG Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global BCG Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Merck BCG Vaccine Product Portfolio
8.1.5 Merck Recent Developments
8.2 Sanofi Pasteur
8.2.1 Sanofi Pasteur Comapny Information
8.2.2 Sanofi Pasteur Business Overview
8.2.3 Sanofi Pasteur BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 Sanofi Pasteur BCG Vaccine Product Portfolio
8.2.5 Sanofi Pasteur Recent Developments
8.3 Japan BCG Lab
8.3.1 Japan BCG Lab Comapny Information
8.3.2 Japan BCG Lab Business Overview
8.3.3 Japan BCG Lab BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Japan BCG Lab BCG Vaccine Product Portfolio
8.3.5 Japan BCG Lab Recent Developments
8.4 China National Biotec
8.4.1 China National Biotec Comapny Information
8.4.2 China National Biotec Business Overview
8.4.3 China National Biotec BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 China National Biotec BCG Vaccine Product Portfolio
8.4.5 China National Biotec Recent Developments
8.5 Serum Institute of India
8.5.1 Serum Institute of India Comapny Information
8.5.2 Serum Institute of India Business Overview
8.5.3 Serum Institute of India BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Serum Institute of India BCG Vaccine Product Portfolio
8.5.5 Serum Institute of India Recent Developments
8.6 Intervax
8.6.1 Intervax Comapny Information
8.6.2 Intervax Business Overview
8.6.3 Intervax BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 Intervax BCG Vaccine Product Portfolio
8.6.5 Intervax Recent Developments
8.7 GSBPL
8.7.1 GSBPL Comapny Information
8.7.2 GSBPL Business Overview
8.7.3 GSBPL BCG Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 GSBPL BCG Vaccine Product Portfolio
8.7.5 GSBPL Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 BCG Vaccine Value Chain Analysis
9.1.1 BCG Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 BCG Vaccine Sales Mode & Process
9.2 BCG Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 BCG Vaccine Distributors
9.2.3 BCG Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. BCG Vaccine Industry Trends
Table 2. BCG Vaccine Industry Drivers
Table 3. BCG Vaccine Industry Opportunities and Challenges
Table 4. BCG Vaccine Industry Restraints
Table 5. Global BCG Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global BCG Vaccine Revenue Share by Company (2019-2024)
Table 7. Global BCG Vaccine Sales Volume by Company (MT) & (2019-2024)
Table 8. Global BCG Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global BCG Vaccine Average Price (USD/Kg) of Company (2019-2024)
Table 10. Global BCG Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global BCG Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global BCG Vaccine Company, Product Type & Application
Table 13. Global BCG Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global BCG Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Immune BCG
Table 18. Major Companies of Therapy BCG
Table 19. Global BCG Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (MT)
Table 20. Global BCG Vaccine Sales Volume by Type (2019-2024) & (MT)
Table 21. Global BCG Vaccine Sales Volume by Type (2025-2030) & (MT)
Table 22. Global BCG Vaccine Sales Volume Share by Type (2019-2024)
Table 23. Global BCG Vaccine Sales Volume Share by Type (2025-2030)
Table 24. Global BCG Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global BCG Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global BCG Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global BCG Vaccine Sales Value Share by Type (2019-2024)
Table 28. Global BCG Vaccine Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Hospitals
Table 30. Major Companies of Clinics
Table 31. Major Companies of Others
Table 32. Global BCG Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (MT)
Table 33. Global BCG Vaccine Sales Volume by Application (2019-2024) & (MT)
Table 34. Global BCG Vaccine Sales Volume by Application (2025-2030) & (MT)
Table 35. Global BCG Vaccine Sales Volume Share by Application (2019-2024)
Table 36. Global BCG Vaccine Sales Volume Share by Application (2025-2030)
Table 37. Global BCG Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global BCG Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global BCG Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global BCG Vaccine Sales Value Share by Application (2019-2024)
Table 41. Global BCG Vaccine Sales Value Share by Application (2025-2030)
Table 42. Global BCG Vaccine Sales by Region: 2019 VS 2023 VS 2030 (MT)
Table 43. Global BCG Vaccine Sales by Region (2019-2024) & (MT)
Table 44. Global BCG Vaccine Sales Market Share by Region (2019-2024)
Table 45. Global BCG Vaccine Sales by Region (2025-2030) & (MT)
Table 46. Global BCG Vaccine Sales Market Share by Region (2025-2030)
Table 47. Global BCG Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global BCG Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global BCG Vaccine Sales Value Share by Region (2019-2024)
Table 50. Global BCG Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global BCG Vaccine Sales Value Share by Region (2025-2030)
Table 52. Global BCG Vaccine Market Average Price (USD/Kg) by Region (2019-2024)
Table 53. Global BCG Vaccine Market Average Price (USD/Kg) by Region (2025-2030)
Table 54. Global BCG Vaccine Sales by Country: 2019 VS 2023 VS 2030 (MT)
Table 55. Global BCG Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global BCG Vaccine Sales by Country (2019-2024) & (MT)
Table 57. Global BCG Vaccine Sales Market Share by Country (2019-2024)
Table 58. Global BCG Vaccine Sales by Country (2025-2030) & (MT)
Table 59. Global BCG Vaccine Sales Market Share by Country (2025-2030)
Table 60. Global BCG Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global BCG Vaccine Sales Value Market Share by Country (2019-2024)
Table 62. Global BCG Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global BCG Vaccine Sales Value Market Share by Country (2025-2030)
Table 64. Merck Company Information
Table 65. Merck Business Overview
Table 66. Merck BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 67. Merck BCG Vaccine Product Portfolio
Table 68. Merck Recent Development
Table 69. Sanofi Pasteur Company Information
Table 70. Sanofi Pasteur Business Overview
Table 71. Sanofi Pasteur BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 72. Sanofi Pasteur BCG Vaccine Product Portfolio
Table 73. Sanofi Pasteur Recent Development
Table 74. Japan BCG Lab Company Information
Table 75. Japan BCG Lab Business Overview
Table 76. Japan BCG Lab BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 77. Japan BCG Lab BCG Vaccine Product Portfolio
Table 78. Japan BCG Lab Recent Development
Table 79. China National Biotec Company Information
Table 80. China National Biotec Business Overview
Table 81. China National Biotec BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 82. China National Biotec BCG Vaccine Product Portfolio
Table 83. China National Biotec Recent Development
Table 84. Serum Institute of India Company Information
Table 85. Serum Institute of India Business Overview
Table 86. Serum Institute of India BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 87. Serum Institute of India BCG Vaccine Product Portfolio
Table 88. Serum Institute of India Recent Development
Table 89. Intervax Company Information
Table 90. Intervax Business Overview
Table 91. Intervax BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 92. Intervax BCG Vaccine Product Portfolio
Table 93. Intervax Recent Development
Table 94. GSBPL Company Information
Table 95. GSBPL Business Overview
Table 96. GSBPL BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 97. GSBPL BCG Vaccine Product Portfolio
Table 98. GSBPL Recent Development
Table 99. Key Raw Materials
Table 100. Raw Materials Key Suppliers
Table 101. BCG Vaccine Distributors List
Table 102. BCG Vaccine Customers List
Table 103. Research Programs/Design for This Report
Table 104. Authors List of This Report
Table 105. Secondary Sources
Table 106. Primary Sources
Table 1. BCG Vaccine Industry Trends
Table 2. BCG Vaccine Industry Drivers
Table 3. BCG Vaccine Industry Opportunities and Challenges
Table 4. BCG Vaccine Industry Restraints
Table 5. Global BCG Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global BCG Vaccine Revenue Share by Company (2019-2024)
Table 7. Global BCG Vaccine Sales Volume by Company (MT) & (2019-2024)
Table 8. Global BCG Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global BCG Vaccine Average Price (USD/Kg) of Company (2019-2024)
Table 10. Global BCG Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global BCG Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global BCG Vaccine Company, Product Type & Application
Table 13. Global BCG Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global BCG Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Immune BCG
Table 18. Major Companies of Therapy BCG
Table 19. Global BCG Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (MT)
Table 20. Global BCG Vaccine Sales Volume by Type (2019-2024) & (MT)
Table 21. Global BCG Vaccine Sales Volume by Type (2025-2030) & (MT)
Table 22. Global BCG Vaccine Sales Volume Share by Type (2019-2024)
Table 23. Global BCG Vaccine Sales Volume Share by Type (2025-2030)
Table 24. Global BCG Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global BCG Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global BCG Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global BCG Vaccine Sales Value Share by Type (2019-2024)
Table 28. Global BCG Vaccine Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Hospitals
Table 30. Major Companies of Clinics
Table 31. Major Companies of Others
Table 32. Global BCG Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (MT)
Table 33. Global BCG Vaccine Sales Volume by Application (2019-2024) & (MT)
Table 34. Global BCG Vaccine Sales Volume by Application (2025-2030) & (MT)
Table 35. Global BCG Vaccine Sales Volume Share by Application (2019-2024)
Table 36. Global BCG Vaccine Sales Volume Share by Application (2025-2030)
Table 37. Global BCG Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global BCG Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global BCG Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global BCG Vaccine Sales Value Share by Application (2019-2024)
Table 41. Global BCG Vaccine Sales Value Share by Application (2025-2030)
Table 42. Global BCG Vaccine Sales by Region: 2019 VS 2023 VS 2030 (MT)
Table 43. Global BCG Vaccine Sales by Region (2019-2024) & (MT)
Table 44. Global BCG Vaccine Sales Market Share by Region (2019-2024)
Table 45. Global BCG Vaccine Sales by Region (2025-2030) & (MT)
Table 46. Global BCG Vaccine Sales Market Share by Region (2025-2030)
Table 47. Global BCG Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global BCG Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global BCG Vaccine Sales Value Share by Region (2019-2024)
Table 50. Global BCG Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global BCG Vaccine Sales Value Share by Region (2025-2030)
Table 52. Global BCG Vaccine Market Average Price (USD/Kg) by Region (2019-2024)
Table 53. Global BCG Vaccine Market Average Price (USD/Kg) by Region (2025-2030)
Table 54. Global BCG Vaccine Sales by Country: 2019 VS 2023 VS 2030 (MT)
Table 55. Global BCG Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global BCG Vaccine Sales by Country (2019-2024) & (MT)
Table 57. Global BCG Vaccine Sales Market Share by Country (2019-2024)
Table 58. Global BCG Vaccine Sales by Country (2025-2030) & (MT)
Table 59. Global BCG Vaccine Sales Market Share by Country (2025-2030)
Table 60. Global BCG Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global BCG Vaccine Sales Value Market Share by Country (2019-2024)
Table 62. Global BCG Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global BCG Vaccine Sales Value Market Share by Country (2025-2030)
Table 64. Merck Company Information
Table 65. Merck Business Overview
Table 66. Merck BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 67. Merck BCG Vaccine Product Portfolio
Table 68. Merck Recent Development
Table 69. Sanofi Pasteur Company Information
Table 70. Sanofi Pasteur Business Overview
Table 71. Sanofi Pasteur BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 72. Sanofi Pasteur BCG Vaccine Product Portfolio
Table 73. Sanofi Pasteur Recent Development
Table 74. Japan BCG Lab Company Information
Table 75. Japan BCG Lab Business Overview
Table 76. Japan BCG Lab BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 77. Japan BCG Lab BCG Vaccine Product Portfolio
Table 78. Japan BCG Lab Recent Development
Table 79. China National Biotec Company Information
Table 80. China National Biotec Business Overview
Table 81. China National Biotec BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 82. China National Biotec BCG Vaccine Product Portfolio
Table 83. China National Biotec Recent Development
Table 84. Serum Institute of India Company Information
Table 85. Serum Institute of India Business Overview
Table 86. Serum Institute of India BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 87. Serum Institute of India BCG Vaccine Product Portfolio
Table 88. Serum Institute of India Recent Development
Table 89. Intervax Company Information
Table 90. Intervax Business Overview
Table 91. Intervax BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 92. Intervax BCG Vaccine Product Portfolio
Table 93. Intervax Recent Development
Table 94. GSBPL Company Information
Table 95. GSBPL Business Overview
Table 96. GSBPL BCG Vaccine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 97. GSBPL BCG Vaccine Product Portfolio
Table 98. GSBPL Recent Development
Table 99. Key Raw Materials
Table 100. Raw Materials Key Suppliers
Table 101. BCG Vaccine Distributors List
Table 102. BCG Vaccine Customers List
Table 103. Research Programs/Design for This Report
Table 104. Authors List of This Report
Table 105. Secondary Sources
Table 106. Primary Sources
LIST OF FIGURES
Figure 1. BCG Vaccine Product Picture
Figure 2. Global BCG Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global BCG Vaccine Sales (2019-2030) & (MT)
Figure 5. Global BCG Vaccine Sales Average Price (USD/Kg) & (2019-2030)
Figure 6. Global BCG Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Immune BCG Picture
Figure 10. Therapy BCG Picture
Figure 11. Global BCG Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
Figure 12. Global BCG Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global BCG Vaccine Sales Volume Share by Type (2019-2030)
Figure 14. Global BCG Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global BCG Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global BCG Vaccine Sales Value Share by Type (2019-2030)
Figure 17. Hospitals Picture
Figure 18. Clinics Picture
Figure 19. Others Picture
Figure 20. Global BCG Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
Figure 21. Global BCG Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global BCG Vaccine Sales Volume Share by Application (2019-2030)
Figure 23. Global BCG Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global BCG Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global BCG Vaccine Sales Value Share by Application (2019-2030)
Figure 26. Global BCG Vaccine Sales by Region: 2019 VS 2023 VS 2030 (MT)
Figure 27. Global BCG Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global BCG Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global BCG Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. North America BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Netherlands BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Nordic Countries BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Nordic Countries BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Nordic Countries BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. China BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. China BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. China BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. Japan BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. Japan BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. Japan BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. South Korea BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. South Korea BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. South Korea BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Southeast Asia BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Southeast Asia BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Southeast Asia BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. India BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. India BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. India BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Australia BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Australia BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Australia BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Mexico BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Mexico BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Mexico BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. Brazil BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. Brazil BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. Brazil BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Turkey BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 89. Turkey BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 90. Turkey BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 91. Saudi Arabia BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 92. Saudi Arabia BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 93. Saudi Arabia BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 94. UAE BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 95. UAE BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 96. UAE BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 97. BCG Vaccine Value Chain
Figure 98. Manufacturing Cost Structure
Figure 99. BCG Vaccine Sales Mode & Process
Figure 100. Direct Comparison with Distribution Share
Figure 101. Distributors Profiles
Figure 102. Years Considered
Figure 103. Research Process
Figure 104. Key Executives Interviewed
Figure 1. BCG Vaccine Product Picture
Figure 2. Global BCG Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global BCG Vaccine Sales (2019-2030) & (MT)
Figure 5. Global BCG Vaccine Sales Average Price (USD/Kg) & (2019-2030)
Figure 6. Global BCG Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Immune BCG Picture
Figure 10. Therapy BCG Picture
Figure 11. Global BCG Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
Figure 12. Global BCG Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global BCG Vaccine Sales Volume Share by Type (2019-2030)
Figure 14. Global BCG Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global BCG Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global BCG Vaccine Sales Value Share by Type (2019-2030)
Figure 17. Hospitals Picture
Figure 18. Clinics Picture
Figure 19. Others Picture
Figure 20. Global BCG Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
Figure 21. Global BCG Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global BCG Vaccine Sales Volume Share by Application (2019-2030)
Figure 23. Global BCG Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global BCG Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global BCG Vaccine Sales Value Share by Application (2019-2030)
Figure 26. Global BCG Vaccine Sales by Region: 2019 VS 2023 VS 2030 (MT)
Figure 27. Global BCG Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global BCG Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global BCG Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. North America BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa BCG Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa BCG Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Netherlands BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Nordic Countries BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Nordic Countries BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Nordic Countries BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. China BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. China BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. China BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. Japan BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. Japan BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. Japan BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. South Korea BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. South Korea BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. South Korea BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Southeast Asia BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Southeast Asia BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Southeast Asia BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. India BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. India BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. India BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Australia BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Australia BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Australia BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Mexico BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Mexico BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Mexico BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. Brazil BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. Brazil BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. Brazil BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Turkey BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 89. Turkey BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 90. Turkey BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 91. Saudi Arabia BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 92. Saudi Arabia BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 93. Saudi Arabia BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 94. UAE BCG Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 95. UAE BCG Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 96. UAE BCG Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 97. BCG Vaccine Value Chain
Figure 98. Manufacturing Cost Structure
Figure 99. BCG Vaccine Sales Mode & Process
Figure 100. Direct Comparison with Distribution Share
Figure 101. Distributors Profiles
Figure 102. Years Considered
Figure 103. Research Process
Figure 104. Key Executives Interviewed
